|Articles|June 1, 1996

Managing the Patient at Risk for NSAID Toxicity Consensus Conference
Volume 2
Issue 8 Suppl

Defining the Patient at Risk for NSAID Toxicity

Author(s)G. James Morgan, MD

Download PDF: Defining the Patient at Risk for NSAID Toxicity

Articles in this issue

about 30 years ago

Article

Participants

about 30 years ago

Article

Goals and Long-Term Management of Arthritis with NSAIDs

about 30 years ago

Article

Overview of the Physiology of COX-1 and COX-2 and Selectivity of NSAIDs

about 30 years ago

Article

Renal Toxicity with NSAIDs: Types, Consequences, Differences, and Management of the Patient at Risk

about 30 years ago

Article

GI Toxicity of NSAIDs: Incidence, Complications, Management Strategy

about 30 years ago

Article

Reaching Consensus on Managing the Patient at Risk for NSAID Toxicity

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Defining the Patient at Risk for NSAID Toxicity

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently

5 Ongoing Clinical Trials in Myeloproliferative Neoplasms

Defunding Co-Payment Assistance Disrupted nAMD Care

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM